PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $350,000 | -9.6% | 68,838 | -6.7% | 0.00% | – |
| Q3 2019 | $387,000 | -9.8% | 73,784 | +5.9% | 0.00% | -100.0% |
| Q2 2019 | $429,000 | +35.3% | 69,688 | +2.0% | 0.00% | – |
| Q1 2019 | $317,000 | -24.7% | 68,307 | -34.2% | 0.00% | -100.0% |
| Q4 2018 | $421,000 | -49.0% | 103,786 | -21.1% | 0.00% | 0.0% |
| Q3 2018 | $825,000 | +16.9% | 131,577 | +39.1% | 0.00% | 0.0% |
| Q2 2018 | $706,000 | 0.0% | 94,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $706,000 | +12.6% | 94,600 | -10.3% | 0.00% | -50.0% |
| Q4 2017 | $627,000 | -18.9% | 105,414 | +0.3% | 0.00% | -33.3% |
| Q3 2017 | $773,000 | +4.9% | 105,100 | -0.8% | 0.00% | -25.0% |
| Q2 2017 | $737,000 | -33.7% | 105,944 | -8.5% | 0.00% | -42.9% |
| Q1 2017 | $1,111,000 | +96.6% | 115,800 | +77.3% | 0.01% | +250.0% |
| Q4 2016 | $565,000 | +69.2% | 65,300 | +11.7% | 0.00% | +100.0% |
| Q3 2016 | $334,000 | – | 58,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |